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This article highlights the research presentations at the satellite symposium on “Brain Pathways to 
Recovery from Alcohol Dependence” held at the 2013 Society for Neuroscience Annual Meeting. 
The purpose of this symposium was to provide an up to date overview of research efforts focusing 
on understanding brain mechanisms that contribute to recovery from alcohol dependence. A panel 
of scientists from the alcohol and addiction research field presented their insights and perspectives 
on brain mechanisms that may underlie both recovery and lack of recovery from alcohol 
dependence. The four sessions of the symposium encompassed multilevel studies exploring 
mechanisms underlying relapse and craving associated with sustained alcohol abstinence, 
cognitive function deficit and recovery, and translational studies on preventing relapse and 
promoting recovery. Gaps in our knowledge and research opportunities were also discussed.
I. Introduction
Extensive research efforts have focused on understanding neurobiological mechanisms 
underlying alcohol dependence. Relatively little attention, however, has been directed at 
understanding the neurobiology of recovery from alcohol dependence. Epidemiological data 
suggests that, among people who are alcohol dependent prior-to-past year, 18.2% could 
maintain abstinence, suggesting the potential of recovery from alcohol dependence (Dawson 
et al., 2005). Although the number of studies is limited, evidence from both human and 
animal studies suggests that recovery from alcohol dependence is a dynamic process and 
that differential brain functional and behavioral changes are associated with different stages 
of abstinence. The mechanisms underlying these changes, their temporal course, and the 
degree to which these changes influence recovery or relapse require careful studies.
Alcohol withdrawal produces a constellation of symptoms and is associated with changes in 
gene regulation, neuronal activity, and behavior. Although a few studies have demonstrated 
these dynamic changes during early to protracted abstinence, little is known on how these 
changes impact recovery. To gain a significant understanding of brain pathways underlying 
recovery, multi-level studies are needed to address changes in various neurobiological 
systems and behaviors during protracted abstinence. Successful recovery has recently been 
associated with changes in alcohol-induced neuroadaptation and brain network rewiring. 
However, it remains not understood how sustained alcohol abstinence alters adaptation of 
neurocircuits driving dependence and how targeted modulations of these neural pathways 
disrupt alcohol associated memory, improve cognitive recovery, and impact other 
parameters, such as sleep dysregulation during abstinence. Thus, studies are needed to 
understand neurobiological mechanisms underlying recovery. Lastly, integrating animal 
models and human studies that target affected neural circuitry should facilitate the 
translation of basic research discovery and help to identify effective treatment strategies to 
ameliorate the devastating consequences of alcoholism. This symposium was sponsored by 
NIAAA and organized by the division of neuroscience and behavior at NIAAA. At the 
symposium, Dr. Kenneth Warren highlighted the recent progress in alcohol neuroscience 
research, and Dr. Changhai Cui gave an introduction overview on brain pathways to 
recovery from alcohol dependence. Speakers Drs. George Koob, Rajita Sinha, Mahesh 
Thakkar, Fulton Crews, Judson Chandler, Adolf Pfefferbaum, Howard Becker, David 
Lovinger, Barry Everitt, Chitra Mandyam, George Fein, and Marc Potenza presented 
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selections of their studies on neurobiological and behavioral changes associated with alcohol 
dependence, abstinence, relapse, and recovery, and highlighted potential behavioral and 
therapeutic strategies to aid the recovery process. Dr. Edith Sullivan moderated the panel 
discussion, and the panelists, including Drs. Kathleen Grant, Adron Harris, Dieter 
Meyerhoff, Marisa Roberto, and Edith Sullivan, provided insightful discussions into the 
presentations, discussed research gaps, and suggested future research directions.
II. Negative Affect Associated with Alcohol Abstinence
II. 1. Compulsive alcohol seeking driven by the negative emotional states associated with 
alcohol abstinence
George F. Koob—Addiction to drugs or alcohol can be defined as a chronic, relapsing 
disorder that has been characterized by (i) a compulsion to seek and take drugs, (ii) the loss 
of control over drug intake, and (iii) the emergence of a negative emotional state (e.g., 
dysphoria, anxiety, and irritability) that defines a motivational withdrawal syndrome when 
access to the drug is prevented (Koob and Le Moal, 1997). Addiction has been 
conceptualized as a three-stage cycle—binge/intoxication, withdrawal/negative affect, and 
preoccupation/anticipation—that worsens over time and involves allostatic changes in the 
brain reward and stress systems that lead to compulsive alcohol taking and seeking. Two 
primary sources of reinforcement, positive and negative reinforcement, have been 
hypothesized to play a role in this allostatic process (Koob and Le Moal, 2001, 2008). 
Positive reinforcement is defined as the process by which the presentation of a stimulus 
increases the probability of a response. Negative reinforcement is defined as the process by 
which the removal of an aversive stimulus (or aversive state in the case of addiction) 
increases the probability of a response (Koob, 2013).
The focus of the present treatise is on the withdrawal/negative affect stage and a specific 
role for the brain stress systems in negative reinforcement. The brain stress systems can be 
defined as neurochemical systems that are activated during exposure to acute stressors or in 
a chronic state of stress and mediate species-typical behavioral responses. Key 
neurotransmitter systems with circumscribed neurocircuitry that mediates behavioral 
responses to stressors include the hypothalamic-pituitary-adrenal (HPA) axis with 
glucocorticoids and extrahypothalamic stress systems with corticotropin-releasing factor 
(CRF) (Koob, 2008). Corticotropin-releasing factor is a 41-amino-acid polypeptide that 
controls hormonal, sympathetic, and behavioral responses to stressors (Lemos et al., 2012; 
Rainnie et al., 2004). Central administration of CRF mimics the behavioral response to 
stress in rodents, and the administration of competitive CRF receptor antagonists generally 
has anti-stress effects (Dunn and Berridge, 1990; Koob, 1994; Koob and Le Moal, 2001; 
Sarnyai et al., 2001).
The brain neurochemical systems involved in arousal-stress modulation have been 
hypothesized to be engaged within the neurocircuitry of the brain stress systems in an 
attempt to overcome the chronic presence of the perturbing drug and restore normal function 
despite the presence of drug (Koob, 2008). Both the HPA axis and extrahypothalamic brain 
stress system mediated by CRF are dysregulated by chronic administration of all major 
drugs with dependence or abuse potential, with a common response of elevated 
Cui et al. Page 3













adrenocorticotropic hormone, corticosterone, and amygdala CRF during acute withdrawal 
(Delfs et al., 2000; Koob, 2009, 1994; Merlo Pich et al., 1995; Olive et al., 2002; Rasmussen 
et al., 2000; Rivier et al., 1984; Roberto et al., 2010). Indeed, activation of the HPA response 
may be an early dysregulation associated with excessive drug taking that ultimately 
“sensitizes” the extrahypothalamic CRF systems (Koob and Kreek, 2007; Vendruscolo et 
al., 2012).
A common response to acute withdrawal and protracted abstinence from all major drugs of 
abuse is the manifestation of anxiety-like responses that are reversed by CRF antagonists. 
Studies using animal models have demonstrated that alcohol withdrawal produces anxiety-
like behavior that is reversed by intracerebroventricular administration of CRF1/CRF2 
peptidergic antagonists (Baldwin et al., 1991) and small-molecule CRF1 antagonists (Funk 
et al., 2007; Knapp et al., 2004; Overstreet et al., 2004) and intracerebral administration of a 
peptidergic CRF1/CRF2 antagonist into the amygdala (Rassnick et al., 1993). The effects of 
CRF antagonists have been localized to the central amygdala (CeA) (Rassnick et al., 1993). 
CRF antagonists injected intracerebroventricularly or systemically also block the potentiated 
anxiety-like responses to stressors observed during protracted abstinence from chronic 
alcohol (Breese et al., 2005; Huang et al., 2010; Overstreet et al., 2007; Valdez et al., 2003; 
Wills et al., 2009).
CRF antagonists also block the compulsive-like responding reflected in the increased self-
administration of alcohol in dependent rats (Funk et al., 2007). For example, exposure to 
repeated cycles of chronic alcohol vapor produced substantial increases in alcohol intake in 
rats during both acute withdrawal and protracted abstinence (2 weeks post-acute withdrawal; 
(O’Dell et al., 2004; Rimondini et al., 2002). Intracerebroventricular administration of a 
CRF1/CRF2 antagonist blocked the dependence-induced increase in alcohol self-
administration during both acute withdrawal and protracted abstinence (Valdez et al., 2002). 
Systemic injections of small-molecule CRF1 antagonists also blocked the increased alcohol 
intake associated with acute withdrawal (Funk et al., 2007) and protracted abstinence 
(Gehlert et al., 2007). When administered directly into the CeA, a CRF1/CRF2 antagonist 
blocked alcohol self-administration in alcohol-dependent rats (Funk et al., 2006). These 
effects appear to be mediated by the actions of CRF on GABAergic interneurons within the 
CeA, and a CRF antagonist administered chronically during the development of dependence 
blocked the development of compulsive-like responding for alcohol (Roberto et al., 2010). 
Altogether, these results suggest that CRF in the basal forebrain may also play an important 
role in the development of the aversive motivational effects that drive the increased drug 
seeking associated with alcohol dependence.
One hypothesis to explain the role of stress systems in the transition to alcohol dependence 
is that the sustained activation of neuroendocrine stress systems (e.g., corticosteroid release 
via the HPA axis) by alcohol intoxication and withdrawal and consequent alterations in 
expression levels of glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) drive 
compulsive alcohol drinking. Rats exposed to alcohol vapor to the point of dependence 
displayed increased alcohol intake, compulsive drinking measured by progressive-ratio 
responding, and persistent alcohol consumption despite punishment compared with control 
rats that were not exposed to alcohol vapor. Chronic GR antagonism with mifepristone 
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(RU38486) prevented the escalation of alcohol intake and compulsive responding induced 
by chronic, intermittent alcohol vapor exposure during both acute withdrawal and protracted 
abstinence (Vendruscolo et al., 2012). Thus, the GR system appears to also be involved in 
the development of alcohol dependence, possibly by driving the extrahypothalamic CRF 
system.
Converging lines of evidence suggest that impairment of medial PFC (mPFC) cognitive 
function and over activation of the CeA also may be linked to the development of 
compulsive-like responding to drugs of abuse during extended access (Briand et al., 2008a; 
Briand et al., 2008b; George et al., 2008). In an animal model of binge alcohol consumption, 
even before the development of dependence, in which rats are given continuous (24 h per 
day, 7 days per week) or intermittent (3 days per week) access to alcohol (20% vol/vol) 
using a two-bottle choice paradigm, Fos expression in the mPFC, CeA, hippocampus, and 
the nucleus accumbens (NAc) were correlated with working memory impairment and 
anxiety-like behavior (George et al., 2012). Abstinence from alcohol in rats with a history of 
escalation of alcohol intake specifically recruited GABA and CRF neurons in the mPFC and 
produced working memory impairments associated with excessive alcohol drinking during 
acute (24–72 h) but not protracted (16–68 day) abstinence. Abstinence from alcohol was 
associated with a functional disconnection of the mPFC and CeA but not mPFC or NAc. 
These rodent study results show that recruitment of a subset of GABA and CRF neurons in 
the mPFC during withdrawal and disconnection of the PFC CeA pathway may be critical for 
impaired executive control over motivated behavior, suggesting that dysregulation of mPFC 
interneurons may be an early index of adaptive changes of neuronal activity in alcohol 
dependence.
The overall conceptual theme argued herein is that compulsive alcohol seeking represents an 
excessive and prolonged engagement of homeostatic brain regulatory mechanisms that 
regulate the response of the body to stressors. The dysregulation of the stress axis may begin 
with the binge and subsequent acute withdrawal, triggering a cascade of changes, from 
activation of the HPA axis to activation of CRF in the PFC to activation of CRF in the 
extended amygdala. How these systems are modulated by other known brain emotional 
systems localized to the basal forebrain, where the extended amygdala projects to convey 
emotional valence, how frontal cortex dysregulations in the cognitive domain linked to 
impairments in executive function contribute to the dysregulation of the extended amygdala, 
and how individuals differ at the molecular-genetic level of analysis to convey loading on 
these circuits remain challenges for future research.
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II. 2. Disrupted stress-related medial prefrontal cortex/anterior cingulate cortex activity 
jeopardizes alcohol recovery
Rajita Sinha—Stress is among the critical risk factors that increase relapse and jeopardize 
recovery from alcoholism (Sinha, 2008). In animal studies, acute and chronic alcohol 
exposure profoundly alters brain stress pathways, including the emotion (amygdala) and 
reward (striatum) regions, to affect alcohol seeking and intake as well as reinstatement 
(Koob et al., 2004). Laboratory studies in humans have also shown acute and chronic 
alcohol to significantly change the biological stress pathways and chronic alcohol abuse 
alters the hypothalamic-pituitary- adrenal (HPA) axis rhythm, the sympathetic and 
parasympathetic autonomic responses as well as increases negative emotions and alcohol 
craving in response to stress and alcohol cues (Sinha, 2001). Furthermore, several of these 
responses such as blunted cortisol responses, stress-induced craving and adrenal sensitivity 
predict future alcohol intake and relapse risk (Sinha, 2011). However, the neural changes 
that may affect relapse risk and jeopardize recovery have not been fully identified in 
humans.
To understand the impact of chronic alcohol abuse on brain function under stress and its 
effects on clinical outcome, 45 4-week recently abstinent inpatient treatment engaged 
alcohol dependent (AD) individuals were studied using functional brain imaging (fMRI). 
After the fMRI session, AD individuals were prospectively followed to assess relapse risk 
and recovery over a 90 day period after discharge from inpatient treatment. In addition, 30 
healthy social drinkers who were well-matched to a subgroup of 30 alcoholic patients also 
participated in an fMRI session. All participants were exposed to stress, alcohol cue and 
neutral relaxing imagery trials in the fMRI session. After discharge from inpatient treatment, 
all alcohol dependent patients returned to the clinic on days 14, 30 and 90 days post-
treatment to assess time to first lapse and to heavy drinking and relapse severity (Seo et al., 
2013).
The abstinent recovering AD patient group compared to controls showed blunted activation 
in ventromedial prefrontal cortex (VmPFC) regions to stress imagery, and exaggerated 
VmPFC activation during relaxed imagery. Individual differences in this pattern of response 
among the AD patient group predicted both alcohol craving during the fMRI scan and future 
relapse risk. Those AD patients with greater VmPFC activity during relaxed state as well as 
those with significantly blunted VmPFC response during stress reported higher alcohol 
craving and were also the patients who relapsed more quickly during the follow-up period. 
Furthermore, high relapse severity, as measured by greater number of days of alcohol use 
after relapse, was independently predicted by blunted VmPFC, insula and ventral striatum 
response to stress as well as heightened VmPFC activity to relaxed imagery conditions. 
Sensitivity and specificity analyses of fMRI revealed that altered VmPFC activity under 
relaxed and stress states most significantly and accurately classified relapsers versus non-
relapsers. These findings suggests that this specific VmPFC response during relaxed and 
stress states in early abstinence and recovery from alcohol may represent a neural signature 
of high alcohol relapse risk (Seo et al., 2013).
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It is well known that chronic stress damages prefrontal cortex structure and function 
(Arnsten, 2009). The mPFC is also a critical component of the corticolimbic-striatal 
addiction circuitry and a number of human neuroimaging studies have shown alcohol related 
alterations in brain prefrontal responses to cognitive and emotional tasks. Basic science 
experimental studies indicate chronic alcohol and withdrawal from alcohol results in 
structural damage to prefrontal neurons, disruption of neuroimmune signaling and functional 
plasticity in prefrontal neural circuits, which in turn, relate to poor executive control and 
function as discussed by Drs. Chandler, Crews, Sullivan and Pfefferbaum in this review. In 
humans, chronic alcohol exposure and repeated withdrawals disrupts functioning of the 
VmPFC (Duka et al., 2011). The VmPFC is involved in behavioral and emotional control, 
regulation of visceral and behavioral responses and decision making (Bechara, 2005). The 
Seo et al. (Seo et al., 2013) findings are consistent with this previous basic science and 
human research on functions of the VmPFC and alcohol effects on these functions and 
directly link dysfunction of this region to high alcohol craving and greater relapse risk in 
alcohol dependence. While needing future replication, these findings identify disrupted 
medial prefrontal function as a neural substrate for increased alcohol craving and increased 
risk of jeopardizing alcoholism recovery. Findings suggest that treatment development that 
targets normalization of ventromedial prefrontal function may serve to decrease alcoholism 
relapse risk and enhance recovery processes.
II.3. Impaired sleep homeostasis is the cause of sleep disruptions associated with 
alcoholism
Mahesh Thakkar—Alcohol has profound impact on sleep. In non-alcoholics, acute 
alcohol intake decreases sleep latency, and increases quality and quantity of non-rapid eye 
movement (NREM) sleep (Roehrs and Roth, 2001a; Sharma et al., 2012). In contrast, 
alcoholics, both during drinking period and during abstinence, suffer from a multitude of 
sleep disruptions manifested by insomnia, excessive daytime sleepiness and altered sleep 
architecture. Furthermore, subjective and objective indicators of sleep disturbances are 
predictors of relapse (Brower, 2001; Roehrs and Roth, 2001b). Finally, within USA, more 
than $18 billion is associated with alcohol-related sleep disorders (Brower, 2001). Thus, 
although alcohol associated sleep disruptions have significant economic and clinical 
consequences, very little is known about how and where alcohol acts to affect sleep.
Sleep is regulated by: 1) circadian process, controlled by the suprachiasmatic nucleus, which 
regulates the timing of sleep, and 2) homeostatic process, which maintains the “constancy” 
of sleep. Thus, sleep deficit results in the accumulation of sleep pressure in the brain which 
begins to dissipate once sleep is initiated (Borbely, 1982). The core of sleep homeostasis is 
sleep propensity or sleep pressure. Sleep pressure starts to accumulate as soon as one is 
awake, and continues to build-up until sleep is initiated. Thus, the more awake you are, the 
sleepier you feel. Once sleep is initiated, sleep pressure starts to dissipate. Sleep pressure is 
the manifestation of a build-up or an accumulation of sleep homeostatic factor.
Although several sleep factors have been identified and implicated to mediate the build-up 
of sleep pressure during wakefulness, only adenosine has gained the utmost attention 
because adenosine links sleep with energy metabolism and neuronal activity (Thakkar et al., 
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2014). During wakefulness, energy (ATP) usage is high in wake-promoting systems, due to 
increased neuronal firing, synaptic activity, and synaptic potentiation. This increased energy 
usage during wakefulness is reflected in increased accumulation of extracellular adenosine, 
a breakdown product of ATP metabolism, which corresponds to increased accumulation of 
sleep pressure. The longer the period of wakefulness, greater the accumulation of sleep 
pressure and/or AD and the longer it takes for sleep pressure to dissipate during sleep 
(Thakkar et al., 2014).
Sleep pressure is measured by theta power in wake EEG and extracellular adenosine, most 
markedly in the wake-promoting the basal forebrain (BF) region. Increased adenosine acts 
via A1 receptors (A1R) to inhibit wake-promoting neurons in the BF to promote sleep and 
enhance delta activity (Thakkar et al., 2003a; Thakkar et al., 2003b). Homeostatic response 
or dissipation of sleep pressure is measured by sleep latency along with the duration and 
intensity of recovery sleep that follows after sleep loss (Borbely 1982; Porkka-Heiskanen 
2013).
About 5 years ago, we began investigating the neuronal mechanisms mediating the effects of 
alcohol on sleep and a brief summary of our salient findings is described below. Of note, 
some results are preliminary as the studies are in progress. Our first set of experiments, 
conducted in male Sprague Dawley (SD) rats, examined the effects of acute alcohol (3.0 
g/Kg; intragastric administration at dark onset) on sleep. Acute alcohol administration 
significantly 1) reduced latency to NREM sleep, 2) increased time spent in NREM sleep, 3) 
reduced time spent in wakefulness and 4) suppressed c-Fos expression in the BF. Local 
bilateral administration of adenosine A1 receptor (A1R) antagonist in the BF attenuated 
alcohol-induced sleep. In a separate study, local BF infusion of alcohol produced a 
significant increase in extracellular adenosine. These results suggest that alcohol may 
interact with the sleep homeostat to promote sleep (Sharma et al., 2010b; Thakkar et al., 
2010).
The second group of experiments examined the effects of binge alcohol drinking on sleep in 
C57BL/6J mice. We used the “drinking in dark” (DID) protocol because it has strong face 
validity in mimicking human binge drinking (Rhodes et al., 2005). Our initial results suggest 
that mice exposed to binge alcohol consumption displayed a reversal of sleep cycle with 
increased NREM sleep during active (dark) period post-binge followed by increased 
wakefulness during their normal sleep (light) period. Furthermore, mice exposed to binge 
alcohol drinking did not develop sleep pressure during sleep deprivation and did not show 
homeostatic response after sleep deprivation suggesting an altered sleep homeostasis.
Our third set of experiments examined sleep in alcohol dependent SD rats. Alcohol 
dependency was induced by Majchrowicz’s chronic binge alcohol protocol (Majchrowicz, 
1975). Our results suggest that alcohol dependent rats displayed severe and protracted sleep 
disruptions. During acute (Day 1 post-treatment) withdrawal, the alcohol dependent rats 
displayed: 1) significant increase in wakefulness, 2) significant increase in the activation of 
BF wake-promoting neurons, 3) No increase in adenosine release in the BF during sleep 
deprivation. 4) Significant reduction in the expression of A1R and equilibrative nucleoside 
transporter 1 (ENT1) in the BF. During post-acute withdrawal (Day 7, post treatment), 
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alcohol dependent rats displayed a reversal of sleep cycle. Based on these results, we believe 
that impaired sleep homeostasis may be the cause of sleep disruptions observed in alcohol 
dependent rats (Sharma et al., 2010a).
Our fourth set of experiments examined the effects of chronic alcohol exposure in C57BL/6J 
mice. Mice were pair fed with the Lieber-DeCarli control and alcohol (6.8%) diet for 3 
weeks followed by 10 days of alcohol withdrawal (Anji and Kumari, 2008). Sleep-
wakefulness was continuously recorded beginning with the onset of alcohol consumption. 
Our preliminary results suggest that chronic alcohol exposure resulted in severe sleep 
disturbances both during drinking period and during withdrawal. Analysis of sleep-
wakefulness on withdrawal day ten suggest profound increase in wakefulness and reduction 
in sleep, both during the normal sleep (light period) and during the active period. Based on 
our initial results, we believe that alcohol may interact with sleep homeostasis to affect 
sleep-wakefulness and cause sleep disruptions.
III. Cognitive Function Deficit and Recovery
III. 1. Persistent increases in Toll-like Receptor signaling and reversal learning deficits in 
abstinence
Fulton T. Crews—Alcoholism is a chronic relapsing disease characterized by continued 
drinking despite negative consequences. Alcohol abuse results in increased expression of 
brain innate immune genes that alter brain function contributing to difficulty to control 
drinking regardless of negative consequences. Toll-like Receptors (TLR) and the 
endogenous TLR agonist, High-Mobility Group Box 1 (HMGB1), have recently been found 
to increase neuronal excitation and to induce neuroimmune genes (Crews et al., 2013b; 
Maroso et al., 2010). We find that alcohol treatment of mice induces activation of TLR 
receptor mediated signaling that potentiates innate immune gene induction by endotoxin 
(lipopolysaccaride, LPS), a TLR4 agonist (Qin and Crews, 2012), and polyIC, a TLR3 
agonist (Qin and Crews, 2012). Alcohol both sensitizes TLR receptor activation and 
increases systemic microbial TLR agonists through a leaky gut. In addition, alcohol can 
release HMGB1 which stimulates TLR4 receptors in the brain increasing mRNA and protein 
levels of interleukin-1 beta (IL1β), tumor necrosis factor alpha (TNFα), and other innate 
immune gene expression (Crews et al., 2013b; Zou and Crews, 2014a). Innate immune gene 
activation in the brain lasts for long periods of time (Qin et al., 2013; Qin et al., 2007). We 
investigated their expression in human orbital frontal cortex, a brain region involved in 
predicting future outcomes of planned behavior and found that HMGB1 levels in the brain 
correlated with TLR expression in the brain (Crews et al., 2013a), which is consistent with 
the hypothesis that increases in this agonist-receptor signaling system cause long lasting 
increases in innate immune gene expression. A comparison of the expression of HMGB1 
with TLR receptors, e.g. TLR2, TLR3, and TLR4 across control, moderate drinkers, and 
heavy alcoholics finds a striking correlation of expression in the orbital frontal cortex 
consistent with increased levels of HMGB1 agonist and TLR receptors contributing to the 
persistent innate immune gene activation in the brain (Crews et al., 2013b). In addition to 
the correlation between HMGB1 and TLR, they also correlate with lifetime alcohol 
consumption (Figure 1) (Crews et al., 2013a). The correlation of human prefrontal cortical 
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expression of HMGB1 and TLR with lifetime alcohol consumption is driven mostly by 
alcoholics consuming between 500 and 6,000 kg of lifetime alcohol since moderate drinking 
controls all cluster on the y axis, having much lower lifetime consumption levels. These 
findings are consistent with long lasting persistent increases in expression of HMGB1 and 
TLRs following binge drinking models in mice (Qin et al., 2013) and rats (Vetreno and 
Crews, 2012). The persistance and cummulative nature of alcohol on HMGB1 and TLR 
gene induction support their involvement in alcohol-induced long term changes in brain 
function that could contribute to the chronic relapsing nature of alcoholism. Increased levels 
of HMGB1 and TLR expression are hypothesized to alter neuronal networks involved in 
frontal cortical executive functions.
Adolescent alcohol abuse is associated with increased risks of late life alcoholism and 
alcohol related morbidity (Grant and Dawson, 1997). Our studies suggest that the plasticity 
of adolescent brain increases risk of alcohol-induced changes in the brain. We modeled 
adolescent binge drinking to determine if innate immune signaling was altered into 
adulthood. Treatment of rats with adolescent intermittent alcohol (AIE) exposure resulted in 
increased expression of TLR4 and HMGB1 in adolescence that persisted through maturation 
to adulthood (Vetreno and Crews, 2012; Vetreno et al., 2013a). Furthermore, other innate 
immune genes were persistently induced and the receptor for advanced glycation 
endproducts (RAGE), another innate immune gene inducing receptor for HMGB1, was 
persistently upregulated into adulthood. Assessment of HMGB1, TLR and RAGE receptors 
in human post-mortem brain indicated that alcoholics have elevated HMGB1, TLR and 
RAGE levels in the prefrontal cortex, which also correlate with age of drinking onset 
(Vetreno et al., 2013a). An early age of drinking onset associates with an increased risk for 
developing alcoholism later in life (Grant and Dawson, 1997). Thus, adolescent alcohol 
abuse results in lifelong changes in innate immune gene expression in the brain and 
increases risks for developing alcohol use disorder.
Alcohol abuse-induced neuroimmune signaling likely contributes to the persistence of 
alcoholism and difficulty of remaining abstinent. Multiple studies have found that 
neuroimmune signaling contributes to alcohol dependence (Figure 2). Our studies have 
focused on the orbital frontal cortex and other frontal cortical areas that likely contribute to 
the motivation and decision making process essential for recovery from alcoholism. In rats 
and mice, AIE treatment leads to adult deficits in reversal learning suggesting blunted 
behavioral flexibility (Coleman et al., 2011; Vetreno et al., 2013b). These findings are 
consistent with alcohol induction of innate immune signaling lasts for long periods of time 
and contributing to lasting changes in neurocircuitry that reduce the ability to change 
behavior and increase reward responses. In support of these findings, naltrexone (250pM) 
blocks ethanol induction of IL1β, TNFα and MCP1 mRNA (Zou and Crews, 2014b), and it 
reduces relapse to heavy drinking as well as being characterized as a TLR4 antagonist 
(Hutchinson et al., 2008). Taken together these findings suggest reducing innate immune 
gene induction in the brain could aid recovery from alcohol dependence.
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III. 2. Plasticity of the medial prefrontal cortex and deficits in executive function following 
chronic alcohol exposure
W. Bailey Glen Jr., Heather Trantham-Davidson, L. Judson Chandler—The 
prefrontal cortex (PFC) is a brain region that mediates higher-order (executive) function. 
Chronic alcohol exposure and withdrawal results in protracted alterations in the structural 
and functional plasticity of the medial PFC, and the organization of the neural networks in 
the PFC have increasingly been shown to be disrupted following alcohol abuse (Beck et al., 
2012; George et al., 2012; Sullivan and Pfefferbaum, 2005). It appears that deficits in the 
cognitive function of the PFC may relate, at least in part, to the alterations in synchronous 
organization of both localized and globally distributed cell assemblies into functionally 
integrated networks regulating executive processes such as working memory (George et al., 
2012; Kroener et al., 2012). It is therefore not surprising that many of the behaviors that 
depend upon optimal activity of the PFC are also impacted by alcohol dependence and 
abuse. There is increasing support for the idea that pharmacological enhancement of 
cognitive processes may represent an effective approach for preventing relapse in the 
abstinent alcoholics.
Dopamine modulation of excitatory and inhibitory neurotransmission in the PFC plays 
critical roles in cognition (Arnsten et al., 1994; Cools and D’Esposito, 2011; Gao et al., 
2003) and may play an alcohol treatment role in the progression of addiction and in abuse 
related cognitive impairments (Trantham-Davidson et al., 2014; Volkow et al., 2006; 
Volkow et al., 1996). The data we presented at this symposium demonstrate that chronic 
intermittent alcohol exposure (CIE) and withdrawal results in changes in a loss of dopamine 
D2 and D4 receptor function in response to selective agonists in acute brain slices obtained 
from the PFC of adult rats subjected to CIE vs. sham air exposure. Consistent with previous 
studies, DA receptors exert complex actions on intrinsic firing in the PFC that depends upon 
receptor subtype and the type of neuron. In control rats, D1 receptor activation increased 
intrinsically evoked firing rates in both pyramidal cells and fast-spiking (FS) interneurons, 
while D2 receptor activation decreased firing in pyramidal neurons but increased firing in 
FS interneurons. D4 receptor activation did not impact pyramidal cell firing rates but did 
increase firing in FS interneurons. While no differences were found in D1 receptor signaling 
following CIE exposure (1 week and 4 weeks), both pyramidal and fast-spiking interneurons 
exhibited loss of D2 receptor modulation of evoked firing and FS interneurons exhibited loss 
of D4 receptor modulation. D2/D4 also modulated bot h evoked NMDA and GABAA 
currents in control rats but this modulation was absent following CIE exposure and 
withdrawal. Further studies will be required to elucidate the mechanisms leading to this loss 
of D2/D4 receptor function. We proposed that CIE-induced loss of D2/D4 function in the 
PFC negatively impacts a variety of processes in structural, functional and behavioral 
plasticity.
Sleep is a critical component of normal cognitive function. Impairments in sleep are 
commonly observed in abstinent alcoholics (Brower and Perron, 2010a) and are strong 
predictors of relapse (Brower, 2003; Brower and Perron, 2010b). Here we present data that 
CIE exposure and withdrawal alters sleep architecture in the CIE exposed rat. One week 
after CIE, rats showed a reduction in time spent asleep during the resting phase (lights off), 
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and a decrease in time spent awake during the active phase (lights on). Interestingly, we 
observe a loss of delta power modulation in non-REM sleep during the light cycle. Since 
delta power during non-REM sleep provides a measure of sleep drive, this indicates that 
normal sleep drive is disrupted by CIE and suggests impairment in the sleep homeostat. 
These observations may further suggest a novel target for pharmacological treatment of 
sleep to reduce the rate of relapse. In fact, preliminary results with the atypical sleep aid 
zolpidem show a recovery of sleep impairments and an improvement in a 24-hour delay 
novel object recognition task, suggesting that sleep treatment may be critical for improving 
cognitive deficits in abstinent alcoholics.
Together, the observations presented at this symposium presentation provide insights into 
alcohol-induced alterations in brain function that may underlie cognitive deficits, and 
highlight areas requiring further research in the pursuit of novel targets for reversing alcohol 
associated cognitive dysfunction.
III. 3. Dynamic course of alcoholism: brain imaging of humans and animal models
Adolf Pfefferbaum, Edith V. Sullivan, Natalie M. Zahr—Alcohol dependence is a 
highly prevalent, universal neuropsychiatric disorder with serious untoward consequences 
on family, work, and personal well - being. Alcoholism is marked by a characteristic profile 
of neuropsychological deficits and damage to selective constellations of neurocircuitry—
notably, frontocerebellar, frontostriatal, and limbic systems—underlying disturbed 
functions. Quantitative neuroimaging and neuropsychological approaches permit tracking 
alcoholism’s dynamic course through periods of sobriety and relapse and reveal evidence for 
neuroplasticity and neuroadaptation of brain structure and functions (e.g., Sullivan et al., 
2013). In humans, long-term, excessive alcohol consumption results in a variety of somatic 
and central nervous system insults that must be parsed from the consequences of normal 
aging on the brain (e.g., Muller-Oehring et al., 2013). Consistent with other neuroimaging 
results (e.g., Holt et al., 2012; Spudich and Ances, 2012), our work provides evidence that 
the study of disease progression in the context of normal aging requires longitudinal study of 
relevant variables (Kroenke et al., 2014; Pfefferbaum et al., 2014). Such studies are essential 
for identifying loci of progressive damage with continued heavy drinking or recovery of 
brain tissue and cognitive and motor functions with prolonged sobriety. Our recent 
longitudinal study used diffusion tensor imaging (DTI) to examine changes in the condition 
of the microstructure of brain white matter in 27 abstaining and 20 relapsing alcoholics 
compared with 56 non-alcoholic controls; the three groups were examined 2–5 times over 1–
8 years. The results, based on 841 DTI scans, revealed that despite considerable compromise 
in regional white matter fibers, the abstainers showed significant improvement over age with 
progression toward normality, whereas the trajectories of the relapsers showed accelerated 
aging beyond that detected in controls (Figure 3) (Pfefferbaum et al., 2014 b).
Given the naturalistic character of human studies of alcoholism, precluding control over 
potentially critical variables, confirmation of factors and mechanisms contributing to 
alcoholism-related structural and functional neurodegeneration and those underlying 
neurorecovery require modeling with longitudinal in vivo study of animals. To model high 
alcohol exposure in rodents, we have used two primary protocols: binge alcohol via 
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intragastric gavage and chronic alcohol via vapor chamber. Binge alcohol exposure is based 
on a modified Majchrowicz protocol (Majchrowicz, 1975) with alcohol (20% w/v) 
administered every 8h (i.e., 3 times/day) for 4 days according to body weight, blood alcohol 
levels (BALs), and behavioral intoxication state (Majchrowicz, 1975). Controls receive 
volumes of 5% dextrose equivalent to 3g/kg alcohol at comparable times and are food 
restricted during binge periods in an attempt to weight yoke the two groups. Magnetic 
resonance imaging is acquired 1) pre-exposure (i.e., baseline), 2) within 2h of the last 
alcohol dose (BALs 250–300 mg/dL), and 3) after 7 days of recovery. The alcohol insult is 
reflected by reliably and significantly increased lateral ventricular volume in the alcohol 
group compared with the control group (Figure 4) (Zahr et al., 2010; Zahr et al., 2013a; Zahr 
et al., 2013b). Alcohol relative to control animals furthermore reveal alterations in MR 
spectroscopy (MRS) derived signals: lower N-acetylaspartate (NAA) and total creatine (tCr) 
and higher choline-containing compounds (Cho) (Zahr et al., 2010; Zahr et al., 2013a; Zahr 
et al., 2013b). At recovery, neither ventricular volume nor MRS metabolite levels 
differentiate groups.
Our chronic alcohol exposure protocol uses vapor chambers where rats are given either 
vaporized alcohol or air (i.e., controls). MRI is acquired 1) pre-exposure (i.e., baseline), 2) 
after 16 weeks of vaporized alcohol (BALs ~300 mg/dL), and 3) after an additional 8 weeks 
of vaporized alcohol exposure (i.e., total 24 weeks, BALs ~450 mg/dL). Although chronic 
alcohol exposure via vapor chamber resulted in ventricular enlargement quantified with MRI 
(Pfefferbaum et al., 2008) and neurochemical changes quantified with MRS (Zahr et al., 
2009) that were similar to those observed following binge intoxication, results were less 
pronounced than those observed in the binge exposure model. The fact that changes in MR 
metrics were attenuated in chronic vs. binge alcohol exposure, despite achieving similar 
BALs at the 2nd time point, suggests neuroadaptation to the presence of continuous, high 
alcohol levels.
In a complementary study, we used the binge model to test the hypothesis that binge alcohol 
-induced ventricular enlargement reflects shifts in fluid distribution rather than atrophy of 
surrounding brain regions, a presumed interpretation for this common in vivo finding. We 
found decreases in tissue water transverse relaxation time (T2) and diffusivity measures 
selective to the thalamus and no volume changes in dorsal or ventral hippocampi, 
caudateputamen, or thalamus. Lack of tissue volume reductions in brain regions adjacent to 
ventricles argues against atrophy as a mechanism of ventricular expansion. Decreased tissue 
water T2, decreased thalamic diffusivity, and a role for both NAA and Cho as osmolytes 
support a mechanism of rapid fluid redistribution during alcohol intoxication to account for 
rapid ventricular volume changes (Zahr et al., 2013b). Shifts of fluid between various brain 
compartments might explain reversibility of ventricular enlargement observed in humans 
following recovery from alcohol abuse (Zipursky et al., 1989), anorexia nervosa (Enzmann 
and Lane, 1977), and prolonged steroid use (Bentson et al., 1978). To the extent that the 
pharmacological effect of alcohol is the primary variable of interest, our animal models 
provide clues to mechanisms of recovery, these data being consistent with our human 
studies indicating that alcoholics who sustain sobriety can have restored function and 
recovery of brain structure.
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IV. Neuroadaptation during Abstinence
IV. 1. Genetic influences and gene expression changes associated with alcohol 
dependence, withdrawal, and relapse drinking
Howard C. Becker—This presentation highlighted the most salient features of an 
established mouse model of alcohol dependence and relapse drinking, and then described 
two experimental approaches utilizing this model to examine neurobiological mechanisms 
and genetic influences that contribute to excessive alcohol consumption associated with 
dependence. Briefly, the model entails linking a limited access (2 hr/day) 2-bottle choice 
(15% alcohol vs. water) drinking procedure with a model of dependence involving chronic 
exposure to alcohol vapor in inhalation chambers. Once stable baseline alcohol consumption 
is established, adult male C57BL/6J mice receive repeated weekly cycles of chronic 
intermittent alcohol (CIE) or control air exposure (16 hr/day×4 days), with 5-day limited 
access drinking test sessions during intervening weeks. Repeated cycles of CIE exposure 
results in escalation of voluntary alcohol drinking while alcohol intake remains relatively 
stable in non-dependent mice (Becker, 2013; Becker and Lopez, 2004; Lopez and Becker, 
2005). Moreover, the increased rate of alcohol intake as well as the greater total amount of 
alcohol consumed in dependent (CIE-exposed) mice produced significantly elevated blood 
and brain alcohol levels relative to that registered in non-dependent mice (Griffin et al., 
2009).
To identify neuroadaptive changes associated with dependence that may underlie the 
escalation in drinking, high-density oligonucleotide arrays were used to profile changes in 
gene expression across several brain regions at various time points following CIE exposure. 
Biotinylated target cRNA derived from prefrontal cortex, hippocampus, and ventral striatum 
was hybridized to mouse Affymetrix 430A GeneChips. Analysis of gene microarray results 
indicated distinct brain-regional and time-dependent changes (Melendez et al., 2012). 
Among many transcriptional changes identified, results indicated a significant down-
regulation in the transcription of brain-derived neurotrophic factor (Bdnf) gene in the 
prefrontal cortex (PFC) following CIE exposure (relative to nondependent controls). This 
transcriptional change was confirmed by quantitative RT-PCR analysis, and analysis of 
BDNF protein content (ELISA) in PFC tissue samples indicated a significant reduction for 
at least 72 hours following final chronic alcohol exposure in dependent mice compared to 
nondependent controls (Melendez et al., 2012). In support of the functional significance of 
this change in BDNF expression, bilateral microinfusion of BDNF (0.5 ug) into the PFC 
following CIE exposure was shown to significantly reduce subsequent alcohol drinking in 
dependent mice without altering intake in nondependent mice. These results suggest that 
cortical BDNF activity plays a role in modulating excessive alcohol drinking associated with 
alcohol dependence. Additionally, these findings indicate the utility of employing genomic 
analyses for not only revealing dynamic brainregional and time-dependent neuroadaptive 
(transcriptional) changes related to alcohol dependence but also for identifying potential 
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novel targets for future drug treatments that more effectively temper excessive alcohol 
drinking associated with dependence.
In another series of studies, a panel of recombinant inbred BXD mouse strains, generated by 
crossing and inbreeding alcohol-preferring C57BL/6J (B6) and alcohol-avoiding DBA/2J 
(D2) inbred strains, were tested to examine genetic influences on drinking in the CIE model. 
The study included a panel of 43 BXD lines along with a group of the progenitor strains 
(C57BL/6J and DBA/2J mice), the former also serving as a positive control. After stable 
baseline ethanol intake was established, one representative mouse from each genotype was 
assigned to the control (air exposure) condition while another mouse from each of the BxD 
strains received four weekly cycles of CIE vapor exposure alternated with 5-day test 
drinking sessions. Groups of C57BL/6J and DBA/2J mice (N= 8/group/strain) were treated 
similarly. Ethanol inhalation exposure settings corresponded to those that typically produce 
blood ethanol concentrations (BEC) in the target range of 200 ± 50 mg/dl. Due to attrition 
(some genotypes did not tolerate this level of chronic ethanol exposure), only mice that 
contributed ethanol intake data during each of four test cycles were included in final 
analysis. As expected, alcohol intake during the baseline phase of the study varied greatly 
across genotypes, with average intake during the last week of baseline limited access 
sessions ranging from 0.9 to 5.6 g/kg. As anticipated, CIE exposure induced a significant 
increase in alcohol drinking in C57BL/6J mice (~3.5 g/kg) relative to their baseline level 
(2.4 g/kg) as well as intake in CTL mice that remained relatively stable over the 4 test cycles 
(~2.6 g/kg). Of significance, voluntary alcohol intake varied greatly among genotypes after 
the four cycles of CIE exposure. As indicated in Table 1, some strains showed increased 
ethanol consumption relative to their baseline level of intake while other strains evidenced a 
decrease in ethanol intake as a function of CIE exposure. The BxD66 strain exhibited the 
largest relative increase in drinking (136% increase), while the BxD43 strain showed the 
greatest CIE-induced decrease in ethanol intake (52% decrease). A number of strains 
showed minimal change in ethanol intake following CIE treatment (e.g., BxD39, BxD16, 
BxD80, BxD74). For comparative purposes, during the fourth test cycle C57BL/6J mice 
evidenced a 51.4% increase in ethanol intake while DBA/2J mice showed a 28.9% decrease 
in ethanol intake relative to their respective baseline levels of consumption. Importantly, the 
magnitude and direction of changes in alcohol intake during each test cycle did not relate to 
blood alcohol levels recorded during the preceding CIE exposure cycle (blood alcohol levels 
remained mostly in the 200–300 mg/dl range across all genotypes and exposure cycles). 
While results from the BxD strains must be viewed as tentative given the small sample size, 
the fact that the two progenitor inbred strains (C57BL/6J and DBA/2J mice) exhibited 
opposite effects in the CIE-drinking model provide support for a significant contribution of 
genotype to this dependence-related phenotype. The profile of results showing large 
differences between BxD strains will need to be confirmed with additional cohorts of 
animals. Notwithstanding that caveat, these data point to the potential significant influence 
of genetic factors that confer vulnerability to escalate drinking in the context of dependence 
as well as resilience to such effects in the model.
Overall, results from the studies reported here illustrate the value of using animal models to 
probe for genomic and neural substrates underlying escalation of alcohol consumption 
associated with dependence. Identification of such pathophysiological adaptations is critical 
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in not only revealing novel targets for development of potential therapeutics but also in 
discovering genetic and physiological processes that may confer resilience to such effects. 
The ultimate goal is to utilize this information to guide clinical investigations focused on 
treatment strategies and facilitate recovery from alcohol use disorders.
IV. 2. Striatal adaptations that are associated with relapse drinking during early and 
protracted abstinence
David Lovinger—Drugs of abuse, including alcohol, are known to alter the function of 
cortical and basal ganglia circuits, and drug actions in this circuitry are thought to contribute 
to high alcohol intake and disorders involving alcohol abuse. While the majority of this 
work has focused on the mesolimbic dopamine system and the nucleus accumbens, it is now 
becoming clear that nigrostriatal and dorsal striatal circuitry also plays key roles in reward, 
drug actions and addiction.
We have focused on acute and chronic alcohol effects on synaptic transmission and 
plasticity in the dorsal striatum, using both mouse and macaque monkey models. Our 
findings indicate that acute alcohol exposure has differential effects on GABAergic synaptic 
transmission in different striatal subregions that control goal-directed versus habitual 
behavior. Acute alcohol exposure potentiates GABAergic transmission via an apparent 
presynaptic mechanism in the dorsomedial striatum, a part of the associative cortical-basal 
ganglia circuit that controls goal directed behavior (Wilcox et al., 2014). In contrast alcohol 
produces presynaptic inhibition of GABAergic transmission in the dorsolateral striatum 
which is part of the sensorimotor cortical-basal ganglia circuit that controls “habitual” 
behaviors. Chronic alcohol exposure suppresses GABAergic transmission in both striatal 
subregions. The hypo-GABAergic state is observed in both mouse (Wilcox et al., 2014) and 
monkey (Cuzon Carlson et al., 2011) sensorimotor striatum. These changes appear within a 
few weeks of the onset of alcohol exposure in mice, and are still observed after prolonged 
(22 day) forced abstinence in the primate model. These synaptic changes are strongly 
correlated with alcohol intake in monkeys, and accompany a shift from variable to highly 
stable drinking patterns. The excitability of striatal projection neurons is also increased 
following prolonged alcohol drinking in monkeys (Cuzon Carlson et al., 2011).
Long-term synaptic depression, a form of plasticity with important roles in skill and 
instrumental learning is lost following chronic alcohol exposure in the dorsolateral striatum 
(DePoy et al., 2013). Indeed, mice exposed to chronic alcohol show improved learning of 
behavioral tasks involving the dorsolateral striatum (DePoy et al., 2013), including habitual 
instrumental responses (Corbit et al., 2012).
The neurophysiological effects of alcohol in the dorsal striatum create a state that the output 
of the regions controlling goal-directed actions is suppressed, while the output of the regions 
that control habitual behavior is enhanced. These changes may begin even during the first 
acute intoxication episode and are well established within weeks of onset of binge-like 
alcohol exposure. These mechanisms appear to foster habitual behavior, including habitual 
alcohol-seeking (Corbit et al., 2012). Habitual alcohol seeking and drinking may not 
underlie relapse per se, but could well contribute to excessive alcohol intake once relapse 
has occurred. When more is learned about what alters the function of these mechanisms and 
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circuits, it will be interesting to determine if excessive drinking can be curtailed through 
manipulation of key molecules in the striatum or elsewhere in the cortical-basal ganglia 
circuitry.
IV. 3. Promoting abstinence by decreasing the impact of drug-associated memories 
through reconsolidation blockade
Barry J Everitt—Drug and alcohol cues are known to induce craving and relapse in 
abstinent humans, as well as relapse to drug seeking in experimental animals (Everitt and 
Robbins, 2005). Several animal experimental models of drug addiction have shown that the 
formation of an association between an addictive drug’s effects and otherwise neutral 
stimuli in the environment through Pavlovian conditioning during drug self-administration 
training results in the ability of these now drug conditioned stimuli (CSs) (or ‘drug cues’) 
subsequently to induce and maintain drug seeking for prolonged periods of time. This 
retards the extinction of drug seeking and induces drug relapse (Everitt et al., 2001). 
Through the predictive association between CS and drug effect, the CS acquires powerful 
and enduring conditioned reinforcing properties, thereby enabling it to support prolonged 
periods of drug seeking behavior. Drug-associated CSs can also enhance drug seeking 
responses when suddenly present in the environment (conditioned motivation, or pavlovian-
instrumental transfer), elicit attention and approach and, in humans, subjective craving states 
that may cause relapse (Cardinal et al., 2002).
There is great therapeutic interest in reducing the behavioral impact of drug cues and to 
prevent them from eliciting craving and relapse to a drug seeking habit (Lee et al., 2005; 
Milton and Everitt, 2010). Attempts to extinguish the powerful acquired properties of drug 
CSs using cue exposure therapies in order to reduce their behavioral impact have not 
generally been successful as a treatment strategy for drug addiction, in part due to the 
context-specificity of extinction. However, the behavioral impact of a CS may be greatly 
reduced by preventing the reconsolidation of the previously learned memories that are 
retrieved and reactivated by its presentation (Lee et al., 2005). Memory reconsolidation is 
the process by which memories are destabilized when briefly reactivated by re-exposing an 
individual to CSs, such as drug cues, and then undergo protein synthesis-dependent 
restabilization so that they persist in the brain (Nader et al., 2000). It has been demonstrated 
that even old, well-established memories require reconsolidation following retrieval; 
therefore, memory reconsolidation could potentially be exploited to disrupt, or even erase, 
the aberrant memories that play a key role in the persistence of addictive behavior and 
relapse during abstinence.
The Cambridge laboratory and other groups have shown that alcohol, cocaine and high 
incentive food memories, as well as fear memories, undergo reconsolidation (Lee et al., 
2005; Milton et al., 2008b; Milton et al., 2012; Sanchez et al., 2010). Memories elicited by 
presentation of discrete, drug-associated CSs undergo this reconsolidation process in the 
amygdala, which depends upon the expression of the plasticity-associated gene zif268 (Lee 
et al., 2005). Knockdown of this gene in the amygdala at memory retrieval prevents the 
reconsolidation of CS-cocaine memories, resulting in the long-term loss of the acquired 
conditioned reinforcing properties of the drug-associated CS and thereby a reduction in drug 
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seeking and the prevention of relapse measured subsequently. Systemic or intra-amygdala 
infusion of an NMDA receptor antagonist, or systemic treatment with a s-adrenoceptor 
antagonist at drug memory reactivation also prevents the reconsolidation of CS-cocaine and 
CS-alcohol memories, resulting in the long-term reduction in the impact of the drug CS on 
drug seeking and relapse (Lee et al., 2005; Lee et al., 2006; Milton et al., 2008b; Milton et 
al., 2012). NMDA receptor blockade at memory retrieval leads to reduced expression of 
zif268 in the amygdala, suggesting a link between neurotransmission events and intracellular 
signaling mechanisms that are engaged at memory retrieval and result in restabilization of 
the memory (Milton et al., 2008a).
Unlike extinction – meaning repeated, non-reinforced drug CS presentation such as that used 
clinically in cue exposure therapy, not the instrumental extinction that characterizes 
extinction-reinstatement procedures in animal models of relapse - memory erasure induced 
by reconsolidation blockade is not followed by spontaneous renewal or reinstatement of 
behavior by subsequent presentation of the CS as occurs, for example, after the extinction of 
pavlovian fear memories. However, it has recently been shown that extinction training soon 
after (about 10 minutes) a brief memory reactivation results in apparent memory erasure 
similar to that seen after reconsolidation blockade. This has been demonstrated for cued 
cocaine and heroin memories in animals and heroin-associated memories in humans, the 
latter resulting in enduring abstinence (Xue et al., 2012). There is a great therapeutic interest 
in cue exposure therapies that might be more effective if conducted after a brief drug 
memory reactivation and without the need of pharmacotherapy.
Research during the last decade has shown that it is possible to disrupt drug and alcohol 
memory reconsolidation and that this has a lasting impact in reducing the tendency to seek 
drugs and to relapse. This could, therefore, provide the basis for development of a pro-
abstinence, anti-relapse treatment for drug and alcohol addiction that would not be as 
sensitive to spontaneous recovery, reinstatement or renewal effects as are current therapies 
based upon cue-exposure, or extinction, although the latter might be made more effective in 
combination with the memory reactivation process that induces reconsolidation processes in 
the brain. Furthermore, treatments based upon the disruption of reconsolidation would be 
predicted to require few, and possibly even a single, treatment with a memory-disrupting 
drug given at drug memory reactivation in order to increase the likelihood of long-lasting 
abstinence from drugs of abuse. This would clearly be advantageous in avoiding the 
compliance and tolerance issues associated with more extended, prophylactic anti-relapse 
treatments.
V. Neuromechanisms of Treatment
V. 1. Relationship between cortical gliogenesis and alcohol use disorders: new avenues 
for novel therapies
Chitra D. Mandyam—Gliogenesis and neurogenesis in the adult brain have been 
conceptualized to be brain regenerative mechanisms. Whether the newly born glia and 
neurons replace diseased cells or dying cells is a question receiving intense focus. In this 
context, particularly interesting is the capacity of the medial prefrontal cortex (mPFC) to 
generate newly born glia, endothelial cells and neurons (Mandyam and Koob, 2012; 
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Somkuwar et al., 2014). Gliogenesis in the adult mPFC generates glial fibrillary acidic 
protein (GFAP) + astroglia to a lesser extent and neuron-glia 2 (NG2)+ glia (also known as 
oligodendrocyte progenitor cells, polydendrocytes or synantocytes) to a greater extent 
(Mandyam and Koob, 2012; Somkuwar et al., 2014). The functional significance of NG2 
gliogenesis in the adult mPFC is unknown. With emerging evidence from several in vitro 
and in vivo models, it is accepted that NG2 glia differentiate into premyelinating 
oligodendrocytes, mediate nonsynaptic events, and may assist with neuronal transmission 
(Allen and Barres, 2009; Belachew et al., 2003; Butt et al., 2002; Dawson et al., 2003; Kang 
et al., 2010; Ligon et al., 2006; Rivers et al., 2008; Somkuwar et al., 2014; Sun et al., 2011; 
Watanabe et al., 2002). These findings have led to proposals that stimulus-related changes in 
central nervous system myelin could be considered a form of neural plasticity, whereby 
(presumably active) axons and dendrites undergo myelination (through NG2 gliogenesis) to 
improve the speed and efficiency of nerve conduction, thus strengthening or synchronizing 
specific neuronal networks (Fields, 2005, 2010).
We have demonstrated that chronic intermittent alcohol vapor exposure (CIE) with 
increased ethanol drinking during acute withdrawal from CIE in adult rats reduces the levels 
of newly born progenitors and their capacity to survive in the mPFC (Richardson et al., 
2009), indicating reduced mPFC progenitors and gliogenesis in ethanol dependent animals. 
The reduction in the number of mPFC progenitors and gliogenesis was not observed in 
animals that experienced ethanol drinking without CIE (nondependent animals). These prior 
observations lead us to the hypothesis that CIE disrupts myelin plasticity by reducing the 
proliferation and survival of myelinating oligodendrocytes and myelin in the mPFC. To test 
the hypothesis, adult rats were exposed to CIE for seven weeks and after 2 h of CIE 
cessation, they were injected with 5-bromo (iodo or chloro)-2′-deoxyuridine (BrdU/IdU or 
CldU) to label proliferating synthesis (S)-phase progenitors and euthanized 2 h later (to 
measure cell proliferation and cell cycle kinetics) or 28 d later (to measure cell survival). 
Immunohistochemical analysis with antibodies against BrdU and oligodendrocyte lineage 
transcription factor 2 (Olig2) was performed to determine CIE--induced alterations in cell 
cycle kinetics and developmental stages of NG2 glia and oligodendrocyte progenitors. 
Western blot analysis with antibodies Olig2, phosphorylated Olig2 and myelin basic protein 
were used to determine changes in levels of proteins associated with maintaining 
oligodendrogenesis and myelinating glia.
In the satellite symposium we presented findings to demonstrate that newly born progenitors 
in the mPFC differentiated into neurogenic basic helix–loop–helix (bHLH) transcription 
factor Olig2-expressing myelinating oligodendrocytes, and that CIE reduced the process of 
myelinating oligodendrogenesis by altering cell cycle kinetics of progenitors and inducing 
hyperphosphorylation of Olig2 at the conserved triple serine motif (S10, 13 and 14) within 
the amino-terminal domain. Specifically, we demonstrated that CIE reduced the levels of 
progenitors actively dividing in the S phase of the cell cycle. CIE also reduced the length of 
the S phase of the cell cycle, indicating a mechanism contributing to CIE-induced reduction 
in proliferation of glial progenitors in the mPFC. These results, combined with altered 
phosphorylation state of Olig2 provide a mechanism underlying CIE-induced reduction in 
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the levels of Olig2 and myelin basic protein in the mPFC during chronic ethanol exposure 
(Kim et al., 2014).
Subsequent studies were performed to determine whether withdrawal from CIE and 
abstinence from excessive drinking in dependent rats produced changes in proliferation and 
survival of glial progenitors in the mPFC. These markers were also examined in 
nondependent animals. Immunohistochemical analysis demonstrated increased number of 
proliferating and surviving BrdU cells in the mPFC in dependent animals and these 
alterations were not evident in nondependent rats. The enhanced proliferation in dependent 
animals did not correlate with the amount of alcohol consumed during prior drinking 
sessions that occurred during CIE, suggesting that the generation of glial progenitors is 
compromised in withdrawn dependent rats. These results indicate that maladaptive patterns 
of excessive drinking leads to compensatory changes in the mPFC, which may in part define 
a cellular basis for PFC-dependent cognitive impairments associated with alcoholism. In 
summary, these data suggest that the inhibition of dependence-enhanced gliogenesis during 
withdrawal may help reverse altered cortical neuroplasticity during protracted abstinence 
and thus may help reduce the vulnerability to relapse and aid recovery.
V. 2. Resting-state synchrony: a potential neurofeedback target oriented treatment for 
alcoholism
George Fein—Alcoholism is characterized by a lack of control over an impulsive and 
compulsive drive toward excessive alcohol consumption despite significant negative 
consequences. These impulsive and compulsive behaviors are related to the reorganization 
of brain functional networks after repeated high level alcohol exposure (Kalivas and 
O’Brien, 2008; Mameli and Luscher, 2011), resulting in increased resting state synchrony 
(RSS) in appetitive drive networks and decreased RSS in inhibitory control networks 
(Volkow et al., 2013). These increased RSS synchrony in the appetitive drive networks may 
underlie the powerful craving response in alcohol and drug dependent individuals while the 
decreased RSS in executive control networks may underlie the poor inhibitory control and 
emotion regulation in these same groups. The work presented here is based on the premise 
that studying the clinical and neurobiological phenomena of long-term abstinence from 
alcoholism should inform alcoholism treatment. Using resting state functional connectivity 
magnetic resonance imaging (rs-fMRI) we observed adaptive changes in brain RSS in long-
term abstinent alcoholics (LTAA) that reverse these network synchrony differences 
associated with the development of dependence. Multi-year abstinent LTAA compared to 
non-substance abusing controls (NSAC) show lower RSS in appetitive drive networks and 
higher RSS in inhibitory control networks (Camchong et al., 2013a), with similar, although 
attenuated effects in short-term (6–15 week) abstinent alcoholics (STAA) (Camchong et al., 
2013c). LTAA with vs. without comorbid stimulant dependence (LTAAS vs. LTAA) show 
commonalities in RSS (e.g., enhanced executive control RSS) as well as differences (e.g., no 
attenuation of appetitive drive RSS in LTAAS) (Camchong et al., 2013b) (Figure 5–6).
Sixty-four channel EEG studies in these same subjects show there are changes in EEG 
measures of brain network RSS that mirror the rs-fMRI results. We propose that EEG RSS 
neurofeedback to move brain network RSS toward that observed in LTAA will facilitate the 
Cui et al. Page 20













brains efforts to achieve and maintain abstinence by mimicking the changes that take place 
in successful long-term abstinence in the community.
V. 3. Using neuroimaging approaches to understand treatment mechanisms
Marc N. Potenza—Although multiple pharmacological and behavioral therapies have 
demonstrated efficacy in the treatment of alcohol dependence and other addictive disorders, 
relatively little is known regarding the precise biological mechanisms through which these 
therapies operate and recovery occurs (Potenza et al., 2011). Integrating neuroimaging 
measures into randomized clinical trials for addictions has significant potential to advance 
the understanding of how treatments work (e.g., identifying the neural correlates of active 
ingredients of behavioral therapies) and for whom therapies might work best (Potenza et al., 
2013). Given that alcohol dependence and other addictive disorders exhibit biological 
commonalities, e.g., shared genetic features (Slutske et al., 2000; Tsuang, 1998) and shared 
neural features relating to reward processing and impulsivity (Balodis et al., 2012; Balodis et 
al., 2013; Beck et al., 2009; Choi et al., 2012; Fineberg et al., 2014; Peters et al., 2011; 
Wrase et al., 2007), understanding the biological mechanisms underlying treatment-related 
change and recovery in non-alcohol addictions may have important clinical implications for 
understanding such mechanisms in alcohol dependence. Neuroimaging approaches provide 
mechanistic insights on drug-dependence that could eventually guide treatment of 
alcoholism
Thus, using neuroimaging approaches that relate to important aspects of addictions and the 
therapies being employed should help facilitate this process (Potenza et al., 2013) and 
eventually guide treatment of alcoholism. For example, as addictions have been described as 
disorders of misdirected motivation (Chambers et al., 2003; Volkow and Li, 2004), using 
functional imaging tasks that assess aspects of cognitive control and reward processing may 
help understand recovery across a range of addictions. Consistent with this approach, we 
have obtained functional magnetic resonance imaging (fMRI) data assessing cognitive 
control (Stroop color-word interference task) and reward processing (monetary incentive 
delay task) from individuals seeking to cease addictive or problematic behaviors relating to 
cocaine use (Brewer et al., 2008; Jia et al., 2011), tobacco smoking (Krishnan-Sarin et al., 
2013), gambling (Potenza et al., 2013), and binge eating (Balodis et al., 2014). Findings to 
date suggest that specific regional corticostriatal-limbic brain activations relate to treatment 
outcomes across disorders. For example, amongst cocaine-dependent adults and nicotine-
dependent adolescents, increased activation in the ventromedial prefrontal cortex during 
Stroop at treatment onset relates prospectively to better outcomes based on cocaine urine 
toxicology results and plasma cotinine levels, respectively (Brewer et al., 2008; Krishnan-
Sarin et al., 2013). Other data indicate that between-group differences in brain activation 
patterns at treatment onset may be more extreme in individuals who fare more poorly during 
treatment (Balodis et al., 2014). Preliminary findings examining individuals with substance-
use disorders suggest that there exist during treatment brain activity changes that are above 
and beyond test/retest effects (DeVito et al., 2012).
Data collected during these studies may be analyzed using not only general-linear-model-
based (GLM-based) approaches, but also alternate, complementary approaches. For 
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example, independent component analysis (ICA) may identify functionally integrated 
activations (or networks) that are not apparent through traditional GLM-based analyses (Xu 
et al., 2013). The application of ICA to previously analyzed data from cocaine-dependent 
individuals permitted identification of five networks relating to Stroop performance, with 
two involving ventral prefrontal cortical and subcortical brain regions linked to cocaine 
abstinence (Worhunsky et al., 2013). Additional approaches investigating intrinsic 
connectivity (Scheinost et al., 2012) have recently been applied to Stroop fMRI data from 
treatment-seeking cocaine-dependent individuals, with findings linking Stroop-related 
connectivity involving subcortical regions (e.g., ventral striatum, thalamus and midbrain) to 
treatment outcome based on urine toxicology measures (Mitchell et al., 2013).
Although fMRI offers particular advantages to understand the neural correlates of cognitive 
processes that might relate to treatments for addictions (Potenza et al., 2013; Potenza et al., 
2011), neuroimaging assessments of white-matter integrity (Xu et al., 2010) neurochemistry, 
(Martinez et al., 2011), and regional brain volumes (Yip et al., 2014) also hold important 
potential for understanding brain mechanisms underlying effective treatments for and 
recovery from addictions. Combining and integrating these and other approaches (e.g., 
genetic and epigenetic data) hold substantial promise for developing improved interventions 
for addictions and lessening the burden that these disorders have on people, families and 
society.
VI. Discussion
In the panel discussion, Dr. Adron Harris emphasized that we have much behavioral and 
some electrophysiological data showing relatively long-lasting effects of alcohol 
dependence. In addition, we are beginning to evaluate the rather prolonged behavioral 
changes that accompany recovery. However, we know almost nothing about the molecular 
mechanisms that underlie persistent behavioral changes and recovery. This symposium 
provided hints from Fulton Crews of long-lasting changes in neuroimmune signaling in 
rodent and human brain, but a causal link to protracted dependence and recovery remains to 
be established. Likewise, Howard Becker is beginning to look for persistent changes in brain 
gene expression in his rodent model of repeated exposures to alcohol vapor. It is likely that 
changes in brain function with time courses of days to weeks in rodents (and longer in 
humans) are due to persistent changes in gene expression. But what are the mechanisms for 
producing long lasting changes in gene expression? These are likely to be epigenetic, 
involving chromatin modifications such as DNA methylation or histone acetylation. The 
perplexing problem of providing long-lasting changes in brain function from molecules 
(proteins, RNAs, lipids) with short half - lives is not unique to addiction, but has been 
central to understanding the persistence of memory. This field has embraced epigenetic 
chromatin changes as a key mechanism underlying memory (Lubin et al., 2011; Peixoto and 
Abel, 2013), and it is likely that similar brain machinery is responsible for long-lasting 
effects of addiction.
Dr. Kathy Grant pointed to the increasing number of studies, animal and human, showing 
the involvement of the prefrontal cortex (PFC) in cellular and circuitry changes associated 
with alcohol dependence and abstinence. One pathway emphasized corticotropin-releasing 
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factor (CRF) in the PFC projecting to the extended amygdala, another the involvement of 
the medial PFC projections to the insula and then the striatum, and a third implied decreased 
cortical input into key striatal areas setting up a bias towards habitual behavior. The good 
news came from imaging data that suggest the cortical function can be restored in some 
individuals following long-term abstinence. Further two talks presented aspects of how to 
improve recovery (a theme of the symposium) with different methods but surely involving 
aspects of PFC function. There were interfering with memory reconsolidation of cues 
associated with alcohol (Dr. Everitt) or through neurofeedback training of brain resting 
states associated with long term abstinence (Dr. Fein). Together with direct evidence that 
chronic heavy drinking can decrease cortical mass, it appears that developing interventions 
targeting the PFC is likely to be highly useful in preventing relapse to alcoholic drinking.
Dr. Marisa Roberto pointed out that early cellular studies in the alcohol field primarily 
attributed/elucidated specific alcohol-related behaviors to the cellular effects of alcohol in 
specific brain regions or nuclei. Exceptional progress has been made in the past decade in 
this regard. Now we are able to recognize specific neuronal ensembles involved in the 
regulation of a specific behavior and tease apart the specific mechanism and cell-type 
dependent network. She discussed studies presented by Drs. Judson Chandler, David 
Lovinger, and Barry Everitt and emphasized two aspects: 1) commonalities among three 
brain regions, i.e.: the dorsal striatum, the prefrontal cortex, and the amygdala, where 
alcohol alters GABA, glutamate and dopamine neurotransmitter systems. All these systems 
are highly sensitive to alcohol. 2) Alcohol may have opposite effects on these 
neurotransmitter systems in each of these brain regions. For instance, after chronic alcohol 
exposure, GABAergic signaling is decreased in the dorsal striatum, not altered in medial 
prefrontal cortex (mPFC), and elevated in amygdala. Similar observations apply to the 
glutamatergic system, and these changes may likely result from alteration in intracellular 
pathways and early genes expression (e.g., zif268) as described by Dr. Everitt. The more we 
understand how these neurobiological systems work under normal conditions and how acute 
and chronic alcohol alter them in animal models and humans, the easier it will be to find 
therapeutic targets.
Dr. Dieter J. Meyerhoff discussed presentations by Drs. Pfefferbaum and Potenza. Both 
speakers presented an array of MR methods (multimodal MR) to answer scientific questions 
that relate to clinically relevant function/behavior. fMRI is meaningful by itself, because it 
measures function, such as reward processing or cognitive control. When other MR methods 
are used (of structure or metabolism or blood flow – which can be complementary), it is 
important to relate these measures and their changes over time to function/behavior, be it 
group membership (presented by Dr. Pfefferbaum in alcohol dependent groups with or 
without HIV infection or by Dr. Potenza as abstinence or relapse) or cognition or other 
behavior, to demonstrate their clinical relevance. In other words, strong brain-behavior 
relationships are needed in controls to be compared to such relationships in patients, in 
whom they can be stage-dependent because of neuroplastic changes during dependence and 
the course of recovery. Overall these studies tell us how complicated and complex the 
construct of addiction is and how difficult to model. They tell us about alcoholism as 
opposed to excessive alcohol drinking. Animal studies, while providing mechanistic 
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understanding, have limitations and need to be further refined. Current animal models might 
not properly model many of these defining factors: premorbid factors, comorbid substance 
use including tobacco (polysubstance use disorder) in the majority of alcohol dependent 
individuals today, nutritional status, physical fitness (exercise), psychiatric comorbidities 
(anxiety, depression), personalities (e.g, impulsivity). These need to be further studied/
isolated in humans as well as in animals (if present and feasible).
Dr. Meyerhoff noted that longitudinal studies will provide better data and have intrinsically 
greater statistical power by virtue of within-subject comparisons. These studies provide data 
of brain neuroplastic change, which is often the harbinger of functional/behavioral change. 
In addition, the full palette of neural correlates of addiction can only be appreciated by also 
studying humans before they develop dependence, ideally with proper attention to risk for 
the prevalent comorbidity.
The moderator of the discussion session, Dr. Edith Sullivan, provided an overall discussion 
that alcoholism is an enduring, devastating, complex human disease that affects all ages. 
Given that the course of alcoholism, including recovery from it, is dynamic, we need to 
consider the particular time in the evolution of the disease at which we conduct the study. 
Considerations include temporal ordering of development of alcohol dependence—Koob’s 
march to the dark side. Further, temporal differences as to when dependence commences 
may have implications for resilience and success of abstinence; early exposure may have 
enduring effects. Alcoholism’s effect is widespread and multifocal. Notable circuitry 
identified with neuroimaging, neurochemistry, and neuropsychology is focused on 
frontostriatal, frontolimbic, frontothalamocerebellar systems. That multiple systems can be 
affected presents a potential basis for heterogeneity of damage profiles. Thus, not all 
alcoholics (or animals) might sustain the same pattern or extent of damage, and not all 
regions are likely to be affected equally. Indeed, some systems may be transiently impaired 
while others sustain permanent damage. The location and extent of damage potentially limits 
the scope and type of recovery possible. Systems considerations also have implications for 
potential success of a drug. Alcoholism seldom occurs without some form of antecedent or 
ultimate comorbidity, which itself needs to be included rather than excluded from realistic 
study. Comorbidities and cofactors are multifaceted, including medical (HIV, sleep 
disorders, PTSD), additional substances of abuse (tobacco, food), genes, environment, and 
developmental and aging stages.
This symposium provided a thoughtful review of basic and translational studies expanding 
our understanding of the neuroscience of alcoholism. Dr. Sullivan suggests that, to pursue 
further research on the potential for recovery based on this rich foundation, further studies 
may include the following: 1) Prospective, longitudinal studies which would allow for 
multifactorial questions to be asked to accommodate the complex reality of human 
alcoholism. These studies would be essential to pursue circuitry changes accommodating to 
alcohol use disorders, address whether a circuit is viable to support pharmacological 
therapy, and identify drug suitable targets. 2) Gene, environment, and gene and environment 
interaction studies. 3) Translational studies, which include animal models of salient factors 
and potential interactions, would address behavioral, pharmacological, and genetic 
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therapeutic efforts. Nonhuman primate studies may be particularly suited to target factors, 
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• Changes in various neurobiological systems and behaviors associated with 
alcohol dependence and abstinence
• Cognitive function deficit and sleep disruption associated with alcohol 
dependence, and the dynamic course of recovery
• Mechanisms underlying relapse and alcohol seeking associated with alcohol 
abstinence
• Translational studies on preventing relapse and promoting recovery
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Correlations of HMGB1 and TLR receptors with lifetime alcohol consumption. Shown is a 
schematic diagram relating binge drinking episodes to increased neuroimmune gene 
expression and human post-mortem orbital frontal cortex expression of HMGB1 and TLR 
receptors in moderate drinking controls and alcoholics [data adapted from (Crews and 
Vetreno, 2011)]. (A) Cycles of Binge Ethanol Exposure Persistently Increase Neuroimmune 
Gene Expression. The x axis represents time illustrating repeated alcohol binges that 
contribute to increased lifetime ethanol consumption and result upregulated neuroimmune 
gene expression (red line) and in increased microglial and astrocytic activation. (B) 
Correlations of individual human TLR2 (r = 0.66, p < 0.01), TLR3 (r = 0.83, p < 0.001), 
TLR4 (r = 0.62, p < 0.01), and HMGB1 (r = 0.83, p < 0.001) immunoreactivity versus 
lifetime alcohol consumption (kg) in alcoholics and moderate drinking controls in orbital 
frontal cortex [adapted from (Crews et al., 2013)].
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Evidence supporting a role for Neuroimmune Signaling Cascades in Ethanol Induced 
Pathology. A simplified schematic of HMGB1, TLR and RAGE signaling cascades that lead 
to increased transcription of proinflammatory innate immune genes. HMGB1 stimulation of 
TLRs leads to kinase and/or reactive oxygen species (ROS) activation of nuclear factor 
kappa B (NF-kB) and activator protein-1 (AP1) the generation increasing transcription of 
proinflammatory genes. Similarly, activation of the RAGE receptor leads to downstream 
activation of NF-κB. The production of NF-κB leads to the secretion of proinflammatory 
gene expression, neuroimmune induction, and cell death. Abbreviations: AP-1: activator 
protein-1; CD14: Cluster of differentiation 14; ERK: Extracellular signal-regulated kinase; 
HMGB1: high-mobility group box-1; IKK: inhibitor of nuclear factor kappa-B; JNK: c-Jun 
N-terminal kinases; LPS: lipopolysaccharide; MyD88: myeloid differentiation primary 
response gene 88; NADPH oxidase: nicotinamide adenine dinucleotide phosphate-oxidase; 
NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; RAGE: receptor for 
advanced glycation end products; ROS: reactive oxygen species; Src: Proto-oncogene 
tyrosine-protein kinase; TIRAP: Toll/Interleukin-1 receptor domain-containing adaptor 
protein; TLRs: Toll-like receptors.
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Plots of individual multifocal cluster FA by age for each alcoholic group: 27 abstainers 
(green), 10 light-drinking relapsers (blue), and 10 heavy-drinking relapsers (red). Each 
participant’s values are connected over time and the age-centered slope of each participant is 
overlaid on the longitudinal data points. The solid gray regression line is the expected 
volume by age regression based on the controls; dotted lines are ±1 and 2 S.D. (modified 
from Pfefferbaum et al. 2014, Figure 2).
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a) Fast spin echo (FSE), b) images, and c) quantification of ventricular volume at each time 
point in the binge alcohol experiment. Ctrl=gray, alcohol =red (from Zahr et al. 2013b, 
Figure 2).
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Example of an appetitive drive region with lower RSS in the nucleus accumbens (NAc) seed 
in abstinent alcoholics. (A) MNI brain in neurological orientation showing regions with 
significantly lower RSS in an appetitive drive network in LTAA than NSAC, intermediate 
trend in STAA. LTAAS did not show a significant reduction in appetitive drive RSS. (B) 
Bar graph illustrates strength of RSS between NAc and appetitive drive regions in abstinent 
alcoholics. Red lines represent significant differences between groups.
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(A) Example of higher RSS between left subgenual anterior cingulate cortex (sgACC) and 
right DLPFC in LTAA and LTAAS when compared to NSAC, with an intermediate trend in 
STAA. (B) Bar graph illustrating strength of RSS differences between groups in RSS.
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Table 1
Percent Change in Ethanol Intake (g/kg) From Baseline Following CIE Exposure in BxD RI Strains.
Strain % Change in EtOH Intakea BEC After CIE Cycle 4b
BxD 43 −52.5 307.1
BxD102 −32.9 365.7
BxD 103 −32.9 221.1
DBA/2J −28.9 ± 12.5 270.3 ± 15.4
BxD 81 −22.8 270.0
BxD 85 −22.4 157.2
BxD 12 −9.8 287.1
BxD 62 −7.3 215.5
BxD 100 −7.0 250.7
Bxd 39 −4.9 242.2
BxD 16 −4.8 250.0
BxD 80 −0.6 234.6
BxD 74 +4.7 302.9
BxD 75 +19.1 322.9
BxD 101 +24.6 318.6
C57BL/6J +51.4 ± 14.4 250.6 ± 28.4
BxD 50 +54.8 223.9
BxD 34 +60.2 235.2
BxD 77 +89.5 257.7
BxD 55 +98.4 166.5
BxD 83 +118.4 356.3
BxD 66 +136.1 280.0
a
Percent change in ethanol intake (g/kg) during Test Cycle 4 from intake during last week of Baseline for all CIE-exposed mice.
b
Blood ethanol concentrations (mg/dL) measured immediately following the fourth CIE exposure cycle.
Values are mean ± S.E.M. for C57BL/6J mice and DBA/2J mice (N = 8/strain). All other values obtained from a single subject/strain.
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